Melphalan
CAS Number
148-82-3Synonym
Alanine nitrogen mustard; Alkeran; Alanine nitrogen mustard; CB 3025; Melfalan; Mephalan; NCI-C04853; L-PAM; Phenylalanine mustard; L-phenylalanine mustard; Phenylalanine nitrogen mustard; Sarcoclorin; L-sarcolysin; P-l-sarcolysin; Sarcolysine; L-3-(para-(bis(2-chloroethyl)amino)phenyl)alanine; 4-(bis(2-chloroethyl)amino)-l-phenylalanine; Para-di(2-chloroethyl)aminophenylalanine
Occurrence/Use
Medicine (alkylating agent- multiple myeloma, ovarian cancer)
Cancer Potency Information
| Latest Criteria: | Proposition 65 NSRLs/MADLs |
|---|---|
| Inhalation Unit Risk (μg/cubic meter)-1: | 3.7 E-2 |
| Inhalation Slope Factor (mg/kg-day)-1: | 1.3 E+2 |
| Oral Slope Factor (mg/kg-day)-1: | 1.3 E+2 |
| Comments/References: |
OEHHA 1992. Expedited Cancer Potency Values and Proposed Regulatory Levels for Certain Proposition 65 Carcinogens. |
Proposition 65
Chemical Status
| Cancer: | Currently listed |
|---|---|
| Reproductive Toxicity : | Currently listed |
Cancer
| Listed as causing : | Listed as causing: Cancer |
|---|---|
| Date of Listing: |
Reproductive Toxicity
| Listed as causing: | Developmental Toxicity | Developmental Toxicity |
|---|---|
| Date of Listing: | |
| Basis for Listing : | Formally Required |
Safe Harbor Levels
| Cancer | |
| Last NSRL/MADL Revision: | 1992 |
|---|
Documents, Presentations, and Publications
| Cancer: |
|
|---|